 |
(1S,3S)-3-amino-4-(difluoromethylene)cyclopentanecarboxylic acid hydrochloride, (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid hydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | West syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2010-09-15 00:00:00 |
| Sponsor | Catalyst Pharmaceuticals, Inc.;355 Alhambra Circle, Suite 1250;Coral Gables, Florida, 33134 |
